‘Compelling Evidence’ Shows HPV Vaccine Is Working
June 27, 2019
(Medscape) – The new meta-analysis included data from 60 million individuals and up to 8 years of postvaccination follow-up. It shows a significant reduction in HPV type 16 and 18 infections, as well as a significant reductions in diagnoses of anogenital warts in teenagers of both genders and young men and women. In addition, there was a significant 51% reduction in cervical intraepithelial neoplasia grade 2+ (CIN2+) in girls aged 15-19 years and a 31% reduction in women aged 20-24 years.